• Value of Triage Treatment Strategies to Distribute Hepatitis C Direct-Acting Antiviral Agents in an Integrated Healthcare System: A Cost-Effectiveness Analysis [Editor's Choice]

    Sep 1, 2022, 00:00

  • Large-Scale Population-Based Surveys Linked to Administrative Health Databases as a Source of Data on Health Utilities in Australia

    Sep 1, 2022, 00:00

  • Predicting Patient-Level 3-Level Version of EQ-5D Index Scores From a Large International Database Using Machine Learning and Regression Methods

    Sep 1, 2022, 00:00

  • A Scoping Review of Item-Level Missing Data in Within-Trial Cost-Effectiveness Analysis

    Sep 1, 2022, 00:00

  • Should We Consider Including a Value for “Hope” as an Additional Benefit Within Health Technology Assessment? [Editor's Choice]

    Sep 1, 2022, 00:00

  • Evaluating the Health-Related Quality of Life of the Rare Disease Population in Hong Kong Using EQ-5D 3-Level

    Sep 1, 2022, 00:00

  • Multiple Sclerosis Progressive Courses: A Clinical Cohort Long-Term Disability Progression Study

    Sep 1, 2022, 00:00

  • The Effect of Biosimilar Prescription Targets for Erythropoiesis-Stimulating Agents on the Prescribing Behavior of Physicians in Germany

    Sep 1, 2022, 00:00

  • Is IQWiG's 15% Threshold Universally Applicable in Assessing the Clinical Relevance of Patient-Reported Outcomes Changes? An ISPOR Special Interest Group Report

    Sep 1, 2022, 00:00

  • Patient-Reported Outcome Measures of Quality of Life in People Affected by Diabetic Foot: A Psychometric Systematic Review

    Sep 1, 2022, 00:00

  • Toward System-Wide Implementation of Patient-Reported Outcome Measures: A Framework for Countries, States, and Regions [Editor's Choice]

    Sep 1, 2022, 00:00

  • The Role of Perceived Utility of Full Health in Age Weighting

    Sep 1, 2022, 00:00

  • Table of Contents

    Sep 1, 2022, 00:00

  • A Bayesian Approach for Incorporating the EQ-5D Visual Analog Scale When Estimating the Health-Related Quality of Life

    Sep 1, 2022, 00:00

  • Involvement of Patients and Medical Professionals in the Assessment of Relative Effectiveness: A Need for Closer Cooperation

    Sep 1, 2022, 00:00

  • Validation of the Physician’s Global Assessment of Fingernail Psoriasis by Rheumatologists Treating Psoriatic Arthritis

    Sep 1, 2022, 00:00

  • An Investigation of Age-Related Differential Item Functioning in the EQ-5D-5L Using Item Response Theory and Logistic Regression

    Sep 1, 2022, 00:00

  • Editorial Board

    Aug 29, 2022, 08:44

  • Editorial Board

    Aug 3, 2022, 08:59

  • “Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs

    Aug 1, 2022, 00:00

  • The Role of Attribute Screening and Choice Set Formation in Health Discrete Choice Experiments: Modeling the Impact of Benefit and Risk Attributes

    Aug 1, 2022, 00:00

  • Defining a Core Data Set for the Economic Evaluation of Precision Oncology

    Aug 1, 2022, 00:00

  • The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case Studies

    Aug 1, 2022, 00:00

  • Public Preferences for Policies to Promote COVID-19 Vaccination Uptake: A Discrete Choice Experiment in The Netherlands [Editor's Choice]

    Aug 1, 2022, 00:00

  • Real-World Impact of Transferring the Dispensing of Hospital-Only Medicines to Community Pharmacies During the COVID-19 Pandemic

    Aug 1, 2022, 00:00

  • A Discrete Choice Experiment to Elicit General Population Preferences Around the Factors Influencing the Choice to Make Clinical Negligence Claims

    Aug 1, 2022, 00:00

  • Common Sense in Dollars and Cents: Context Matters in Cost-Effectiveness Checklist Evaluations

    Aug 1, 2022, 00:00

  • Author Reply

    Aug 1, 2022, 00:00

  • Table of Contents

    Aug 1, 2022, 00:00

  • Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report [Editor's Choice]

    Aug 1, 2022, 00:00

  • The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis

    Aug 1, 2022, 00:00

  • The Impact of Banning Electronic Nicotine Delivery Systems on Combustible Cigarette Sales: Evidence From US State-Level Policies

    Aug 1, 2022, 00:00

  • Copyright/Subscription

    Aug 1, 2022, 00:00

  • Preexisting Condition Protections Under the Affordable Care Act: Changes in Insurance Coverage, Premium Contributions, and Out-of-Pocket Spending

    Aug 1, 2022, 00:00

  • Brief Cost Analysis of Surgical Personal Protective Equipment During the COVID-19 Pandemic

    Aug 1, 2022, 00:00

  • Americans’ Health Priorities During the COVID-19 Pandemic

    Aug 1, 2022, 00:00

  • A National Catalog of Mapped Short-Form Six-Dimension Utility Scores for Chronic Conditions in the United States From 2010 to 2015

    Aug 1, 2022, 00:00

  • Emerging Therapies for COVID-19: The Value of Information From More Clinical Trials [Editor's Choice]

    Aug 1, 2022, 00:00

  • Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults

    Aug 1, 2022, 00:00

  • Value of Reducing Wait Times for Chimeric Antigen Receptor T-Cell Treatment: Evidence From Randomized Controlled Trial Data on Tisagenlecleucel for Diffuse Large B-Cell Lymphoma

    Aug 1, 2022, 00:00

  • A Systematic Review of Economic Evaluations of COVID-19 Interventions: Considerations of Non-Health Impacts and Distributional Issues

    Aug 1, 2022, 00:00

  • Considering Severity in Health Technology Assessment: Can We Do Better?

    Aug 1, 2022, 00:00

  • Development and Pilot Test of the Registry Evaluation and Quality Standards Tool: An Information Technology–Based Tool to Support and Review Registries [Editor's Choice]

    Aug 1, 2022, 00:00

  • The Sensitivity and Specificity of Repeated and Dominant Choice Tasks in Discrete Choice Experiments

    Aug 1, 2022, 00:00

  • MSR55 Detecting Generalized Pustular Psoriasis Exacerbations in Unstructured Clinical Data Using Deep Neural Networks

    Jul 15, 2022, 18:17

  • HSD75 Frequency and Risk Factors for the Development of Drug Related Problems in Hospitalized Patients with Rheumatoid Arthritis

    Jul 1, 2022, 00:00

  • EE251 Cost-Effectiveness of an Enhanced Patient Care (EPC) Intervention on Viral Suppression Among Adults Living with HIV in Kenya

    Jul 1, 2022, 00:00

  • EE60 A Review of Analyses Evaluating the Economic Impact of Oral Versus Intravenous Formulations

    Jul 1, 2022, 00:00

  • Cost-Effectiveness of a Core Antigen–Based Rapid Diagnostic Test for Hepatitis C

    Jul 1, 2022, 00:00

  • EE209 Real-World Opioid Overdose Patient Trends, Costs, and Comorbidities in the United States (2016-2019)

    Jul 1, 2022, 00:00

  • EE286 Post-Infusion Monitoring Costs By Site of Care Among Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL) Who Received Second-LINE Treatment with Lisocabtagene Maraleucel (LISO-CEL) in the Transform Study: A United States ...

    Jul 1, 2022, 00:00

  • CO57 Cardiovascular Outcomes in Patients with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease Initiating SGLT2 or GLP-1 Medications within Federated-Real-World Data

    Jul 1, 2022, 00:00

  • CO39 Patient Preferences for Attributes of Advanced Migraine Prevention Medications: Findings from a Discrete Choice Experiment

    Jul 1, 2022, 00:00

  • HSD133 Factors Influencing Selection of First Add-on Disease-Modifying Therapy for Rheumatoid Arthritis after Starting Methotrexate

    Jul 1, 2022, 00:00

  • EE339 Economic Impact Analysis of the Incorporation of the Elecsys sFlt-1/PIGF Ratio for the Diagnosis and Follow-up of Pregnant Women with Suspected Preeclampsia in Argentina

    Jul 1, 2022, 00:00

  • EE290 Direct Medical Cost-Calculator Tool - Economic Burden of Physically Restraining Patients with Agitation and Schizophrenia in Emergency Departments

    Jul 1, 2022, 00:00

  • MSR38 Comparison of Mixture-Cure Model Versus Standard Parametric Survival Model in 1L Diffuse Large B-Cell Lymphoma

    Jul 1, 2022, 00:00

  • EPH38 Accessibility of Essential Medicines for Children in Sichuan Province of China: a Cross-Sectional Study

    Jul 1, 2022, 00:00

  • CO116 Comparative Effectiveness of a Bilayered Living Cellular Construct and a Split Thickness Skin Graft for the Treatment of Venous Leg Ulcers

    Jul 1, 2022, 00:00

  • HTA4 Applicability of Willingness to Pay Thresholds for Oncology Drugs: A Review of Submissions Made to the Canadian Agency for Drugs and Technologies in Health

    Jul 1, 2022, 00:00

  • CO56 Association of Long-Term Prescription Opioid Use with Advanced Stage Cancer at Diagnosis Among Older Cancer Survivors with Non-Cancer Chronic Pain Conditions (NCPCS)

    Jul 1, 2022, 00:00

  • EE93 The Budget Impact of Introducing Monocyte Distribution Width (MDW) As a Screening Tool for Sepsis in China

    Jul 1, 2022, 00:00

  • Development of an EQ-5D Value Set for India Using an Extended Design (DEVINE) Study: The Indian 5-Level Version EQ-5D Value Set

    Jul 1, 2022, 00:00

  • EE424 Burden of Disease Estimation for Heart Failure in Colombia

    Jul 1, 2022, 00:00

  • EE175 Cost Effectiveness of Empagliflozin vs. Ertugliflozin in Patients with Type-2 Diabetes

    Jul 1, 2022, 00:00

  • EE92 Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test for HR+/HER2- Early-Stage Breast Cancer in the US

    Jul 1, 2022, 00:00

  • EE109 A Systematic Review of Cost of Schizophrenia Treatment and the Potential Role of Long Acting Injectables in Easing Economic Burden: A Perspective from 5 Asian Nations

    Jul 1, 2022, 00:00

  • EE380 Economic Burden of Alzheimer's Disease and Mild Cognitive Decline in Colombia

    Jul 1, 2022, 00:00

  • EE154 Burden of Invasive Extraintestinal Pathogenic E. coli Disease Among Older Adult Patients Treated in Hospitals in the US

    Jul 1, 2022, 00:00

  • EE59 Economic Evaluation of Dapagliflozin for the Treatment of Patients with Heart Failure and Reduced Ejection Fraction in Mexico

    Jul 1, 2022, 00:00

  • Award Winners

    Jul 1, 2022, 00:00

  • HPR57 Health Technology Assessment and the Private Health Insurance Sector in Brazil: A Scoping Review

    Jul 1, 2022, 00:00

  • EPH111 Factors Associated with Cancer Prevention Surgeries for Hereditary Cancer Risk in Arkansas 2013-2018

    Jul 1, 2022, 00:00

  • CO30 Clinical Experiences of Type 2 Diabetes (T2DM) Patients Initiating Oral Semaglutide

    Jul 1, 2022, 00:00

  • EE276 Patient Characteristics and Healthcare Resource Utilization in Patients with Chronic Inflammatory Demyelinating Polyneuropathy: A Nationwide Population-Based Study in Sweden

    Jul 1, 2022, 00:00

  • EE213 Cost-Effectiveness Analysis of Axicabtagene Ciloleucel, Brexucabtagene Autoleucel, and Standard of Care for Treatment of Relapsed/Refractory Mantle Cell Lymphoma

    Jul 1, 2022, 00:00

  • CO140 Efficacy and Safety of Flavonoids in Adults with Hemorrhoidal Disease: A Systematic Review

    Jul 1, 2022, 00:00

  • EE46 Venetoclax in Combination with Azacitidine Is Cost-Effective Vs. AZA for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Perspective

    Jul 1, 2022, 00:00

  • MSR46 Visualizing Meaningful Change in Small Sample Sizes

    Jul 1, 2022, 00:00

  • EE145 Increasing Out-of-Pocket Costs By Stage Among Commercially Insured Patients Diagnosed with Cancer 2016-2020

    Jul 1, 2022, 00:00

  • EE391 Budget Impact of Andexanet ALFA for Gastrointestinal Bleeding Associated with Factor Xa Inhibitors from a US Hospital Perspective

    Jul 1, 2022, 00:00

  • HTA27 How Dual Branding of Drugs Impacts Reimbursement Decision in Multiple Myeloma?

    Jul 1, 2022, 00:00

  • EE366 Contrasting Three HbA1c Progression Equations Using the IQVIA Core Diabetes Model

    Jul 1, 2022, 00:00

  • HPR7 Alignment with Services Providers was the Single Most Challenging Change in the Brazilian National Agency for Private Healthcare System (ANS) Value-Based Healthcare (VBHC) Project.

    Jul 1, 2022, 00:00

  • EPH145 Assessing the Relationship between Heart Disease and Related Comorbidities with Dementia and Alzheimer's Disease

    Jul 1, 2022, 00:00

  • EE341 Hospital Costs Associated with Cataract, Glaucoma, Vitreoretinal, and Laser Refractive Surgeries: A Targeted Literature Review

    Jul 1, 2022, 00:00

  • CO104 Efficacy of Memantine in Preventing Neurocognitive Dysfunction Induced By Radiation Therapy in Patients with Brain Metastases: A Systematic Review of Clinical Trials

    Jul 1, 2022, 00:00

  • EE57 Real-World Reductions in Migraine-Related Health Care Resource Utilization and Costs for Patients Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis

    Jul 1, 2022, 00:00

  • EE273 Budget Impact of Lixisenatide/Insulin Glargine in the Treatment Oftype 2 Diabetes Mellitus in Guatemala

    Jul 1, 2022, 00:00

  • Development and Methods for Quality-of-Life, Health Utilities and Patient-Centered Measures

    Jul 1, 2022, 00:00

  • CO54 Medication Regimen Complexity in the Critical Care Unit: Association with Length of Stay, Need for Invasive Mechanical Ventilation, and ICU Mortality

    Jul 1, 2022, 00:00

  • HTA65 The Relationship between Globotriaosylceramide (GB3), Globotriaosylsphingosine (LYSO-GB3) and Disease-Related Clinical Events in Patients with Fabry Disease

    Jul 1, 2022, 00:00

  • HSD28 Cosmetic Dermatology Product Use in Specialty Dermatology Networks

    Jul 1, 2022, 00:00

  • CO130 Subgroup Analysis of Quality-of-Life Outcomes in Patients Achieving F-VASI75: Pooled Results from Two Randomized Phase 3 Studies of Ruxolitinib Cream for the Treatment of Vitiligo

    Jul 1, 2022, 00:00

  • EE4 Cost-Effectiveness Analysis of Trastuzumab Emtansine in the Treatment of Patients with HER2+ Early Breast Cancer (EBC) and Residual Disease after Neoadjuvant Treatment in Colombia

    Jul 1, 2022, 00:00

  • HPR63 Logistical and Financial Challenges in the Adoption of CAR-T Therapies: A Narrative Review

    Jul 1, 2022, 00:00

  • Do Medicine Shortages Reduce Access and Increase Pharmaceutical Expenditure? A Retrospective Analysis of Switzerland 2015-2020

    Jul 1, 2022, 00:00

  • EE441 The Value of Population Screening for CDC Tier 1 Genomic Conditions

    Jul 1, 2022, 00:00

  • EPH57 Variations in Comorbidity Burden in Patients with Type 2 Diabetes over Disease Duration: A Population Based Analysis of Real World Evidence

    Jul 1, 2022, 00:00

  • HSD49 Variability in Incidence of Circulatory and Endocrinal Complications Post COVID-19

    Jul 1, 2022, 00:00

  • EE481 Incorporating Dynamic Pricing in Cost-Effectiveness Analysis: Are Known Unknowns Worth It?

    Jul 1, 2022, 00:00

  • EE37 Real-World Treatment Patterns and Healthcare Costs Among Patients with Adhesive Capsulitis in the United States

    Jul 1, 2022, 00:00

  • EE310 Cost-Effectiveness of Initiating Antihypertensive Therapy with Single-Pill Combinations Versus Monotherapy in US Adults

    Jul 1, 2022, 00:00

  • EE165 Cost-Effectiveness Analysis Model of Aspirin and Aspirin Combination Therapy in Acute Ischemic Stroke Patient in West Sumatera

    Jul 1, 2022, 00:00

  • EE459 Is Adding Ribociclib to Fulvestrant Cost-Effective in Treating Post-Menopausal Women with HR+/ HER2- Advanced Breast Cancer - a US Payer Perspective Cost-Utility Analysis

    Jul 1, 2022, 00:00

  • P7 Elicitation of Health State Utilities Associated Progression from BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC) Health States

    Jul 1, 2022, 00:00

  • EE367 Cost-Effectiveness Analysis of Upadacitinib As a Treatment Option for Patients with Rheumatoid Arthritis in Kingdom of Saudi Arabia

    Jul 1, 2022, 00:00

  • EE257 Budget Consequences of Five Benign Prostatic Hyperplasia Treatment Options - US Medicare Perspective

    Jul 1, 2022, 00:00

  • HSD111 Rational Prescribing of Antidementia Agents to Medicare Beneficiaries

    Jul 1, 2022, 00:00

  • EPH47 Common and Serious Complications Among Patients with Glycogen Storage Disease Type III (GSDIII)

    Jul 1, 2022, 00:00

  • EPH54 Epidemiological Disease Burden of Non-Insulin-Dependent Diabetes Mellitus without Complications Based on Routinely Collected Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • EE17 Budget Impact Analysis of the Incorporation of Tiotropium Bromide Monohydrate-Olodaterol Hydrochloride in Chronic Obstructive Pulmonary Disease in the Chilean Public Health Sector

    Jul 1, 2022, 00:00

  • Real-World Evidence for Comparative Effectiveness, Safety and Adherence Evaluations

    Jul 1, 2022, 00:00

  • EPH154 Assessment of Performance Characteristics of COVID-19 ICD-10-CM Diagnosis Code U07.1 Using Sars-COV-2 Nucleic Acid Amplification Test Results in the US FDA Best Network

    Jul 1, 2022, 00:00

  • MSR10 An Adaptation of the RAND/UCLA Modified Delphi Panel Method in the Time of COVID-19

    Jul 1, 2022, 00:00

  • EE176 Cost-Effectiveness of Etonogestrel Subdermal Contraceptive Implant (ESI) Compared to Levonorgestrel Intrauterine Device (LNG-IUD) Reimbursed on the Brazilian Private Health Insurance and Plans

    Jul 1, 2022, 00:00

  • HPR58 Identifying Geographically Clustered Health Inequalities in England

    Jul 1, 2022, 00:00

  • EPH42 Patient Factors Associated with the Use of Second-Generation Antidiabetic Medications Among Patients with Type 2 Diabetes

    Jul 1, 2022, 00:00

  • EE385 Cost and Health Care Resource Utilization (HCRU) in Patients Starting Intravitreal Dexamethasone (DEX) or ANTI-Vascular Endothelial Growth Factor (AVEGF) in Patients with Diabetic Macular Edema (DME)

    Jul 1, 2022, 00:00

  • CO153 Survival Analyses and Indirect Treatment Comparisons (ITCS) in First-Line Metastatic Urothelial Carcinoma (1L MUC)

    Jul 1, 2022, 00:00

  • EE350 Economic Burden of Recurrence Among Resected Early Stage NSCLC Medicare Patients

    Jul 1, 2022, 00:00

  • HPR25 Use of Patient Preferences Data Regarding Multiple Risks to Inform Regulatory Decisions

    Jul 1, 2022, 00:00

  • EE340 A Targeted Literature Review to Inform Future Economic Evaluations of Huntington's Disease

    Jul 1, 2022, 00:00

  • EE318 Real-World Economic Burden of the at-Risk Opioid Overdose Patients (AROODP) Trends and Naloxone Use in the United States (2016-2019)

    Jul 1, 2022, 00:00

  • EPH27 Comparing Self-Reported Presenteeism with Objectively Measured Direct and Indirect Costs, Lost Time and Comorbidity Assessments for Employees with Agency for Healthcare Research and Quality Skin Conditions

    Jul 1, 2022, 00:00

  • P20 Risk of Antimuscarinic Initiation with Cholinesterase Inhibitor Use in Patients with Alzheimer's Disease

    Jul 1, 2022, 00:00

  • EPH73 Risk Factors for Recurrences of Clostridioides Difficile Infection in the Medicare Population Age 65+ YEARS

    Jul 1, 2022, 00:00

  • HPR48 Health Plan Coverage of High Value Drugs: An Empirical Analysis

    Jul 1, 2022, 00:00

  • EE207 Pharmacoeconomic and Pharmacoepidemiological Analysis of Changes in the Practice of Perioperative Antibiotic Prophylaxis in a Multi-Specialty Surgical Hospital Based on the Local Real-World Data

    Jul 1, 2022, 00:00

  • CO22 Adjusting Survival Data for Treatment Crossover in the ELEVATE-TN Trial By Using a Historical Cohort of Patients Treated with Chemoimmunotherapy in Front-Line Chronic Lymphocytic Leukemia

    Jul 1, 2022, 00:00

  • EE312 The Economic Burden of Moderate-to-Severe Ulcerative Colitis in the EU5

    Jul 1, 2022, 00:00

  • CO151 Ankle Fracture: Understanding Post-Operative Outcomes in the US Commercially Insured Population

    Jul 1, 2022, 00:00

  • CO118 Prevalence of Immunotherapy Use and Survival Disparities By Racial Groups in Patients with Non-Small Cell Lung Cancer in Texas

    Jul 1, 2022, 00:00

  • CO145 Two-Year Outcomes Following Total Hip Replacement with ACTIS - a Matched Comparative Analysis from a US Healthcare System

    Jul 1, 2022, 00:00

  • EPH89 An Individual Patient Data-Based Meta-Analysis of the Relative Reactogenicity of the Infant Doses of Two Licensed Dtap-Backboned Hexavalent Vaccines

    Jul 1, 2022, 00:00

  • Recommendations for the Electronic Migration and Implementation of Clinician-Reported Outcome Assessments in Clinical Trials

    Jul 1, 2022, 00:00

  • EE210 Value of Expanding First-Line Treatment Choices: New Metrics for Economic Evaluation

    Jul 1, 2022, 00:00

  • EE267 A Short-Term Cost-Effectiveness Analysis of Insulin Degludec/Insulin Aspart Versus Insulin Glargine U100 and Insulin Aspart in Patients with Type 2 Diabetes Inadequately Controlled on BASAL Insulin

    Jul 1, 2022, 00:00

  • EPH142 Epidemiological Disease Burden and Cost of Illness of Psoriasis in the US

    Jul 1, 2022, 00:00

  • EE278 Economic Burden of Acute Myeloid Leukemia Relapse in US Patients

    Jul 1, 2022, 00:00

  • HTA66 Outcomes Examined in Clinical Trials of Medicines for COVID-19: A Review of Regulatory Agencies' Websites

    Jul 1, 2022, 00:00

  • EE477 Budgetary Impact Analysis of Alteplase - Recombinant Tissue Plasminogen Activator (RTPA) - As a Thrombolytic Treatment for Acute Ischemic Stroke in Colombia

    Jul 1, 2022, 00:00

  • CO51 A Real-World Retrospective Study Evaluating Safety, Effectiveness, and Cost of Intranasal Esketamine for Treatment-Resistant Depression

    Jul 1, 2022, 00:00

  • HSD126 Pilot Testing a Web-Based Mobile App Designed to Increase Communication and Care Coordination Among Patients, Physicians and Pharmacists

    Jul 1, 2022, 00:00

  • EE113 Comparing Partitioned Survival and State Transition Modeling Approaches: A Case Study of Osimertinib Versus Pemetrexed-Platinum

    Jul 1, 2022, 00:00

  • EE494 Adaptation and Validation of the Nigerian (IGBO) Version of the WHOQOL-OLD Module

    Jul 1, 2022, 00:00

  • CO33 Methodological Challenges and Considerations for Decision Makers When Assessing within-Class Comparative Effectiveness and Cost-Effectiveness: The Case of Non-Vitamin K Antagonist Oral Anticoagulants

    Jul 1, 2022, 00:00

  • CO128 Genetic Biomarkers in Multiple Sclerosis: An Umbrella Review of Meta-Analyses of Observational Studies

    Jul 1, 2022, 00:00

  • EE292 Effectiveness and Cost-Effectiveness for Non-Pharmaceutical Interventions in Chinese Prehypertensive Patients: A Network Meta-Analysis and Markov Model Analysis

    Jul 1, 2022, 00:00

  • HSD131 Alopecia Areata: Trends in Real-World Treatment Patterns in the United States

    Jul 1, 2022, 00:00

  • CO83 An Early Look at Literature-Based Survival Trends in Oncology Tumors: Using AI to Synthesize Published Overall Survival Data across Time in Multiple Myeloma (MM), Acute Myeloid Leukemia (AML) and Glioblastoma (GB)

    Jul 1, 2022, 00:00

  • EPH65 The Public Health Impact of Routine Vaccination in 16-40-Year-Old Females for the Prevention of Cytomegalovirus and Congenital Cytomegalovirus in the United States

    Jul 1, 2022, 00:00

  • HSD27 Optimizing Antimicrobials Use in Hemodialysis Patients: The Role of Clinical Pharmacist, a Retrospective Study

    Jul 1, 2022, 00:00

  • HPR30 Reimbursement Pathway for Advanced Therapy Medicinal Products in Bulgaria

    Jul 1, 2022, 00:00

  • EE235 Costs of Implementing an Adolescent Transition Package to Facilitate Transition to Adult Care for Adolescents with HIV in Kenya

    Jul 1, 2022, 00:00

  • CO8 Health-Related Quality of Life Reported By Patients of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

    Jul 1, 2022, 00:00

  • Health Service Delivery Process of Care

    Jul 1, 2022, 00:00

  • EPH122 Epidemiological Disease Burden of Female Infertility of Tubal Origin Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • CO10 Association of Pimavanserin with Mortality Compared to Quetiapine for Parkinson's Disease Psychosis in Medicare Beneficiaries: 2016-2018

    Jul 1, 2022, 00:00

  • EE446 The Missing Link: Evaluating Economic Outcomes of an Uncoded Novel Diagnostic from Claims Data

    Jul 1, 2022, 00:00

  • EPH44 Relationship between Concurrent Use of Opioids and Gabapentin and Falls Among Older Adults with Chronic Opioid Therapy

    Jul 1, 2022, 00:00

  • CO38 Comparative Safety Assessment of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome after Percutaneous Coronary Intervention

    Jul 1, 2022, 00:00

  • CO11 Chemoprevention for Familial Adenomatous Polyposis with Non-Steroid Anti-Inflammatory Drugs: A Systematic Review and Network Meta-Analysis

    Jul 1, 2022, 00:00

  • EE195 Economic Burden of Patients with Gastroesophageal Reflux Disease in Chinese

    Jul 1, 2022, 00:00

  • HPR6 An Overview of New Payment System for Innovative Medical Technologies in Korea

    Jul 1, 2022, 00:00

  • EPH64 Trends in Cancer Mortality in Colombia, 1979-2019

    Jul 1, 2022, 00:00

  • HSD54 Adherence to Expert Recommendations: Evidence from Oral vs. Infusion Substitution during COVID-19

    Jul 1, 2022, 00:00

  • EPH137 Digital Health Solutions for Workers: Engagement with a Digital Tool for Management of SARS-COV-2 Exposure and Infection

    Jul 1, 2022, 00:00

  • EE250 Cost-Utility Analysis of Dapagliflozin in Patients with Heart Failure in Dominican Republic

    Jul 1, 2022, 00:00

  • HPR50 Life-YEARS Gained with Conditional Reimbursement Access to Innovative Oncological and Hematological Medicines in Finland

    Jul 1, 2022, 00:00

  • EPH166 Is Equitable Access to Care Affecting Depression in Patients with Irritable Bowel Syndrome?

    Jul 1, 2022, 00:00

  • EE198 Cost-Effectiveness of Sacubitril/Valsartan for the Treatment of Essential Hypertension in Chinese Setting

    Jul 1, 2022, 00:00

  • HTA58 A Systematic Review of Digital Technology Use By Clinical Pharmacists

    Jul 1, 2022, 00:00

  • EPH135 The Effect of Lockdown on Reducing Hospitalisations Associated with COVID-19 in Australia

    Jul 1, 2022, 00:00

  • EE91 Driving Value through Innovation

    Jul 1, 2022, 00:00

  • EE393 Incremental Burden of Depression on Direct and Indirect Medical Costs Among Individuals with Irritable Bowel Syndrome in the United States

    Jul 1, 2022, 00:00

  • HSD129 Managing Members with Complex Conditions: A Blue Cross and Blue Shield of Louisiana Program Evaluation

    Jul 1, 2022, 00:00

  • CO97 Effectiveness of Letermovir for Cytomegalovirus Prophylaxis in Seropositive Allogeneic Hematopoietic STEM Cell Transplant Recipients: A Global Systematic Review

    Jul 1, 2022, 00:00

  • CO50 Impact of Frailty on Survivals of Prostate Cancer Patients Treated with Radiotherapy

    Jul 1, 2022, 00:00

  • EE396 Healthcare Costs Among Real-World Patients with Recurrent or Metastatic Cervical Cancer (r/mCC) Receiving Second-Line (2L) Treatment

    Jul 1, 2022, 00:00

  • HTA16 An MCDA Approach to Identify Direct Relationships Between Health States in Markov Chains for Heart Failure Treatments

    Jul 1, 2022, 00:00

  • EE377 The Clinical Economic Burden of Treatment Resistant Depression in the GCC: The Kingdom of Saudi Arabia, Kuwait and the United Arab Emirates

    Jul 1, 2022, 00:00

  • EE219 Beyond Appearan Original Vs Generic Anticoagulants Cost-Benefit Analysis

    Jul 1, 2022, 00:00

  • EE49 Economic Burden of Disease in Patients with Exudative Age-Related Macular Degeneration Using Common Data Model in South Korea

    Jul 1, 2022, 00:00

  • MSR22 Is Artificial Intelligence Replacing Humans in Systematic Literature Reviews? a Systematic Literature Review

    Jul 1, 2022, 00:00

  • EE73 Cost-Effectiveness of Comprehensive Genomic Profiling in Patients with Non-Small Cell Lung Cancer for the Colombian Health System

    Jul 1, 2022, 00:00

  • HSD19 Impact of Coronavirus Disease (COVID-19) Pandemic on Non-COVID Healthcare Utilization in Saudi Arabia

    Jul 1, 2022, 00:00

  • EE373 Cost-Effectiveness of Statins, Ezetimibe and PCSK9 Inhibitor for Secondary Prevention of Cardiovascular Disease

    Jul 1, 2022, 00:00

  • HPR72 Predictors of Food Insecurity in a Sample of Informal Caregivers in Southern States in the United States

    Jul 1, 2022, 00:00

  • EE274 Estimated Costs of Adverse Event Management in NSCLC Patients with Epidermal Growth Factor Receptor Exon 20 Insertion Mutations Treated with Amivantamab or Mobocertinib after Progression on Platinum-Based Chemotherapy

    Jul 1, 2022, 00:00

  • EPH151 Epidemiological Disease Burden of Seropositive Rheumatoid Arthritis Based on Routinely Collected Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • HPR18 The Missing Claimants of 2020: Who Went without Claims in Canada during the First Year of the COVID-19 Pandemic and What Does It Mean for Public and Private Insurers?

    Jul 1, 2022, 00:00

  • EPH140 SARS-COV-2 Breakthrough Infections Among the Healthcare Workers Post-Vaccination with ChAdOx1 nCoV-19 Vaccine in the South Indian State of Kerala

    Jul 1, 2022, 00:00

  • EE245 Cost-Effectiveness of Therapeutic Hypothermia for Neonates with Mild Hypoxic-Ischemic Encephalopathy

    Jul 1, 2022, 00:00

  • EE217 Lost Therapeutic Benefit of Delayed LDL-C Control and Cost-Effectiveness Analysis of Lipid-Lowering Intensification

    Jul 1, 2022, 00:00

  • HSD29 Costs and Healthcare Resource Use Data in Mitochondrial Diseases Associated with Seizures: A Systematic Literature Review

    Jul 1, 2022, 00:00

  • Applying Disparate Data Sources and Methods for Evaluating Real-World Evidence

    Jul 1, 2022, 00:00

  • HSD120 Real-World Treatment Patterns Among US Adults with Alopecia Areata: A Retrospective Claims Analysis

    Jul 1, 2022, 00:00

  • EE159 Cost Effectiveness of Pembrolizumab Combined with Chemotherapy Vs. Chemotherapy As First-Line Treatment for Metastatic TNBC That Expresses PD-L1 in the United States

    Jul 1, 2022, 00:00

  • HPR65 Payment Mechanisms in Non-Prioritized Surgeries: What Effects Do Payment Systems Generate in Public Providers for the Surgical Approach of Morbid Obesity?

    Jul 1, 2022, 00:00

  • HSD97 Use Machine Learning (ML) Techniques to Identify the Likelihood of Hospitalization for High-Risk Patients Diagnosed with COVID 19

    Jul 1, 2022, 00:00

  • CO78 Efficacy and Safety of Brigatinib in ALK-Positive Non-Small Cell Lung Cancer Treatment: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • EE13 Converting Discrete Event Simulation Networks (DESNETS) into Dice Models

    Jul 1, 2022, 00:00

  • CO5 Completeness of Real-World Data (RWD) in Chimeric Antigen Receptor T-Cell Therapy (CAR-T) for Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in United States (US) Community Oncology/Hematology Practices (CH/OS)

    Jul 1, 2022, 00:00

  • EPH139 COVID-19 Vaccine Related Adverse Events in a Population Aged 5–17 Years: A Study of Reports from the VAERS Database

    Jul 1, 2022, 00:00

  • MSR2 Rising Risk: A New Dimension to Consider When Building Predictive Risk Models at Blue Cross and Blue Shield of Louisiana

    Jul 1, 2022, 00:00

  • MSR53 Is Some Anticoagulant Prescription Data Missing in Your Atrial Fibrillation Population? An Approach to Attaching Prescription Data Omitted from Health Plan Claims

    Jul 1, 2022, 00:00

  • EPH141 Assessing Cardiovascular Disease (CVD) Risk By Fibrosis Stage Defined By Fibrosis-4 (FIB-4) Among Patients with Non-Alcoholic Steatohepatitis (NASH) Using Real World Data (RWD)

    Jul 1, 2022, 00:00

  • HSD128 Evaluating the Healthcare Resource Utilization and Costs for Payers and Patients for Atrial Fibrillation in Rural and Urban Settings

    Jul 1, 2022, 00:00

  • EE112 A Population-Level Macroeconomic Model of the Potential Societal Impact of Using Tissue VS. Mechanical Surgical Aortic Valves in Mainland China

    Jul 1, 2022, 00:00

  • EE74 Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Cost-of-Illness Study in Brazilian Private Healthcare Settings

    Jul 1, 2022, 00:00

  • HTA33 The Current Impact of ICER Assessments on Payer Decision Making

    Jul 1, 2022, 00:00

  • EE52 Defining and Measuring Health System Pressure: A Conceptual Framework and Application to RSV and C. Difficile Infections

    Jul 1, 2022, 00:00

  • HPR46 Employment Decrease Among Patients Newly Diagnosed with Early Versus Late-STAGE Cancers in the US

    Jul 1, 2022, 00:00

  • CO52 Syndesmosis Repair: Understanding Post-Operative Outcomes in the US Commercially Insured Population

    Jul 1, 2022, 00:00

  • EPH134 Sex-Gender Differences in COVID-19 Diagnosis, Hospitalization and Mortality

    Jul 1, 2022, 00:00

  • EE94 Health Economic Evidence for Adjuvant Chemotherapy in Stage II and III Colorectal Cancer: A Systematic Review

    Jul 1, 2022, 00:00

  • HPR23 Analysis of Patient Turnover Data and Patient and Medical Delay Data of Lung Cancer Patients between 2016-2020

    Jul 1, 2022, 00:00

  • EE184 Global and Regional Economic Burden of Herpes Simplex Virus Infection

    Jul 1, 2022, 00:00

  • EPH84 Effectiveness of HIV Pre-Exposure Prophylaxis for Prevention of HIV: A Retrospective Cohort Analysis

    Jul 1, 2022, 00:00

  • EE183 Cost-Effectiveness Analysis of Early Versus Delayed Use of Abemaciclib Combination Treatment in Patients with HR+/HER2- High-Risk Early Breast Cancer: A US Payer Perspective

    Jul 1, 2022, 00:00

  • EE457 Long-Term Cost Effectiveness of Mavacamten for Treatment of Hypertrophic Obstructive Cardiomyopathy (HOCM)

    Jul 1, 2022, 00:00

  • EPH99 Antipsychotic Initiation Among Older Alzheimer's Disease Patients Using Cholinesterase Inhibitors and/or Antimuscarinics

    Jul 1, 2022, 00:00

  • EE351 Estimated Annual Treatment Cost of Hemophilia A Prophylaxis in the United States: Comparison of Jivi® with the Other Extended Half Life (EHL) Factor VIII Products

    Jul 1, 2022, 00:00

  • HSD76 Process Mining to Estimate Treatment Cost for the Entire Episodes of Colorectal Cancer Care Using Linked Data

    Jul 1, 2022, 00:00

  • EE294 Burden of Behavioral Health Conditions Among Individuals with Vitiligo in an Insured US Population

    Jul 1, 2022, 00:00

  • EE253 Economic Impact of Implementing Treat-and-Extend Protocol in Age-Related Macular Degeneration (AMD) in a Health Insurance Company in Brazil

    Jul 1, 2022, 00:00

  • EE472 Use of Resources and Economic Cost of the Treatment of Pulmonary Arterial Hypertension for the Social Security and Private Perspective of Argentina

    Jul 1, 2022, 00:00

  • EE289 Ablation Index in Catheter Ablation of Atrial Fibrillation: A Cost-Utility Analysis in Belgium and Germany

    Jul 1, 2022, 00:00

  • P44 Multiple Myeloma Total Direct Costs in Colombia: A National Cohort Study Based on Administrative Claims Databases

    Jul 1, 2022, 00:00

  • EE285 Cost-Effectiveness of Evolocumab Versus Standard Therapy for the Treatment of Dyslipidemia in Patients with Cardiovascular Disease in Qatar

    Jul 1, 2022, 00:00

  • EE397 Potential Budget Impact of Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes Being Treated with Standard of Care

    Jul 1, 2022, 00:00

  • HSD38 Breast and Stomach Cancer Healthcare Fragmentation Associated with Clinical and Economic Outcomes: A National Cohort Study in Colombia

    Jul 1, 2022, 00:00

  • EE321 A Re-Examination of a Cost-Minimization Analysis in Multiple Sclerosis: Assessing Biases from the Inaccurate Assumption of Equal Effectiveness Using Probabilistic Sensitivity Analysis (PSA)

    Jul 1, 2022, 00:00

  • HPR59 Targeted and Immunotherapies for Cancer - Reimbursement and Expenditure in a Single-Payer Healthcare System in Bulgaria

    Jul 1, 2022, 00:00

  • EE232 A Real-World (RW) Comparison of Healthcare Expenditures in Patients Prescribed Aripiprazole Tablet with Sensor (AS) and Patients Prescribed Aripiprazole Alone [Aripiprazole without Sensor (ARI)] in the US

    Jul 1, 2022, 00:00

  • CO36 Network Meta-Analysis (NMA) to Assess Comparative Efficacy of Lenvatinib Plus Pembrolizumab Compared with Other First-Line Treatments for Management of Advanced Renal Cell Carcinoma (ARCC)

    Jul 1, 2022, 00:00

  • HTA30 Paying for Digital Health Interventions: A Rapid Review of Payers' Evidence Frameworks

    Jul 1, 2022, 00:00

  • EE103 Cost-Effectiveness Analysis of the Smart Quit Clinic Program in Cardiovascular Disease Patients in Thailand

    Jul 1, 2022, 00:00

  • Epidemiology Public Health

    Jul 1, 2022, 00:00

  • CO46 Examination of Patient Delay and Medical Delay Among Patients Diagnosed with Lung Cancer

    Jul 1, 2022, 00:00

  • Exploration of the Reasons Why Health State Valuation Differs for Children Compared With Adults: A Mixed Methods Approach

    Jul 1, 2022, 00:00

  • EPH28 Impact of COVID19 on Mental Health - Focus on Depression Anxiety

    Jul 1, 2022, 00:00

  • HPR21 Characteristics and Treatment Patterns of Tofacitinib Users in Taiwan, 2015-2019

    Jul 1, 2022, 00:00

  • EE48 Cost-Effectiveness of Alternative Diagnostic Testing Pathways with Whole Exome Sequencing (WES) in a Rare Disease Patient Population: The Canadian Care-for-Rare SOLVE (SOLVE) Multi-Centre Observational Cohort

    Jul 1, 2022, 00:00

  • HTA13 Updating Nice Evidence Standards Framework for the Effectiveness and Economic Impact of Digital Health Technologies

    Jul 1, 2022, 00:00

  • EE430 Utilization of Medical Records Versus Insurance Claims for Outcomes Research: Learnings from Validation of an Ovarian Cancer Lines of Therapy Algorithm

    Jul 1, 2022, 00:00

  • CO155 Evaluation of the Use of Surrogate Outcomes in Oncology Clinical Trials

    Jul 1, 2022, 00:00

  • HSD60 Children's COVID-19 Vaccination and Race - a Nationwide Survey of Children's Vaccination Status and Trust in the U.S. General Population

    Jul 1, 2022, 00:00

  • EE3 Cost-Effectiveness of Intravenous Antibiotics Therapy for Children with Acute Gastroenteritis in a Secondary Care Hospital in South India

    Jul 1, 2022, 00:00

  • EE225 Economic and Clinical Impact of a Novel, Antiviral Therapy on COVID-19 in the US

    Jul 1, 2022, 00:00

  • EPH62 How Effective Is Antidepressant Medication (ADM) Polypharmacy in Difficult to Treat Depression (DTD)? a Neuroblu Electronic Health Record (EHR) Report

    Jul 1, 2022, 00:00

  • HPR32 An Assessment of Breast Cancer Drug Innovation in the United States (1980-2021)

    Jul 1, 2022, 00:00

  • HPR3 To Wait or Not to Wait: Foregone Option Value for Cell and Gene Therapies

    Jul 1, 2022, 00:00

  • EE297 Systematic Review of Economic Evaluations of C-Reactive Protein Point-of-Care Testing in Primary Care: Do We Need to Do Better?

    Jul 1, 2022, 00:00

  • CO123 Characterizing Key Clinical Outcomes Among Patients with Duchenne Muscular Dystrophy (DMD): Results from a 20-Year Population-Based Study

    Jul 1, 2022, 00:00

  • EE167 Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma

    Jul 1, 2022, 00:00

  • HTA45 Care for Rare: Market Access Evidentiary Requirements for Rare Cancers

    Jul 1, 2022, 00:00

  • CO71 Investigating the Secondary Care System Burden of Glycogen Storage Disease Type IA (GSDIA) Using the HES Database

    Jul 1, 2022, 00:00

  • EE173 Direct Cost Components of Lupus Nephritis in Brazilian Private Healthcare: An Expert Panel Approach

    Jul 1, 2022, 00:00

  • EPH20 Does a Mother's Previous Experience with COVID-19 Infection Change Her Intention to Vaccinate Her Children

    Jul 1, 2022, 00:00

  • EE258 Estimating QALY Gains of Oncology Drugs: A Review of Cost-Utility Analysis of Negotiated Drugs in China

    Jul 1, 2022, 00:00

  • EE35 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Vs. Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Non-Squamous, Advanced Non-Small Cell Lung Cancer in the USA

    Jul 1, 2022, 00:00

  • EE186 Cost-Utility of Nivolumab Versus Observation for the Adjuvant Treatment of Urothelial Carcinoma (UC) for Patients Who Are at High-Risk of Recurren A United States (US) Payer Perspective

    Jul 1, 2022, 00:00

  • EPH144 Hormone Therapy and Risk of Alzheimer's Disease in Women: A Systematic Review and Meta-Analysis

    Jul 1, 2022, 00:00

  • EPH29 Metformin Use Is Associated with Reduced Incidence of Invasive Pneumococcal Disease after a Pneumococcal Vaccine in Adults with Type 2 Diabetes: A Retrospective Cohort Study

    Jul 1, 2022, 00:00

  • HPR56 Challenges of Funding Orphan Medicinal Products in Canada: Quantification of Approval Rate and Reimbursement

    Jul 1, 2022, 00:00

  • CO14 Mapping of Hand Hygiene Habits of Nurses

    Jul 1, 2022, 00:00

  • EE428 Healthcare Resource Utilization Patterns in United States Patients with Rett Syndrome

    Jul 1, 2022, 00:00

  • HSD37 Understanding Preferences of Surgeons for Surgeries Using Discrete Choice Experiment: Take Radical Prostatectomy as an Example

    Jul 1, 2022, 00:00

  • EE21 The Economic Burden of Severe Haemophilia a without Inhibitors Among Adults with Health Insurance Coverage in the United States: Insights from the "Cost of Haemophilia across the US: A Socioeconomic Survey" CHESS US and CHESS US+ Studi ...

    Jul 1, 2022, 00:00

  • EE298 Clinical Manifestations and Health Care Resource Utilization of Eosinophilic Granulomatosis with Polyangiitis (EGPA) in China: A Cross-Sectional Multi-Center Physician Survey Study

    Jul 1, 2022, 00:00

  • EE33 Evaluating the Economic Burden of Acute Myeloid Leukemia in Canada

    Jul 1, 2022, 00:00

  • EPH15 A Simulation Modeling Study to Support Personalized Breast Cancer Prevention and Early Detection in High-Risk Women

    Jul 1, 2022, 00:00

  • EE89 Total Cost of Care and Out-of-Pocket Spending for Medicare Fee-for-Service Beneficiaries with Advanced Melanoma, Advanced Renal Cell Carcinoma, or Advanced Non-Small Cell Lung Cancer

    Jul 1, 2022, 00:00

  • HPR9 An Updated Review of FDA Warning and Untitled Letters for Clinical Outcome Assessment Claims between 2013 and 2020

    Jul 1, 2022, 00:00

  • EPH36 Risk Factors for Amputation in Japanese Patients with Critical Limb Ischemia Based on a Claims Database Analysis

    Jul 1, 2022, 00:00

  • EE10 Cost-Effectiveness of Tenofovir/Lamivudine/Efavirenz Versus Tenofovir/Lamivudine/Dolutegravir for Preventing Mother-to-Child Transmission of HIV in Nigeria

    Jul 1, 2022, 00:00

  • HPR67 Changes in the Practising Nurses Density per 100 Hospital Beds in European Healthcare Systems

    Jul 1, 2022, 00:00

  • CO24 Real-World Patient Characteristics, Efficacy and Safety of Psychiatric Intramuscular Ketamine Treatment: A Retrospective Cohort Study of 452 Outpatients

    Jul 1, 2022, 00:00

  • CO101 A Systematic Literature Review of Randomized Controlled Trials Reporting Efficacy and Safety of Treatments in Patients with Advanced Prostate Cancer in Asian Countries

    Jul 1, 2022, 00:00

  • EE354 Heterogeneity in the Economic Value of Early Alzheimer's Disease-Modifying Therapies: An Analysis of Patient Subgroups

    Jul 1, 2022, 00:00

  • HSD116 Real-World Utilization Patterns of Oncology Biosimilar Monoclonal Antibodies and Their Corresponding Reference Products

    Jul 1, 2022, 00:00

  • EPH110 Endocrine Therapy and Risk of Dementia in Patients with Breast Cancer: A Systematic Review

    Jul 1, 2022, 00:00

  • EPH50 Characterization of Clinical Features and Treatment of Non-Small Cell Lung Cancer (NSCLC) STAGE III and IV in Brazil- a Retrospective DATA-Base Study

    Jul 1, 2022, 00:00

  • HSD83 Are We 'Choosing Wisely?' A Case of Conventional Radiation Therapy in Older Women with Breast Cancer

    Jul 1, 2022, 00:00

  • MSR45 Smooth Algorithm: An Automatic Method to Estimate the Most Likely Drug Combination in Electronic Health Records. Development and Validation Study

    Jul 1, 2022, 00:00

  • HTA40 Challenges in Evaluating and Paying for Combination Therapies in Oncology - a Canadian Perspective

    Jul 1, 2022, 00:00

  • CO132 Duration of COVID-19 and Long COVID - a US Healthcare Database Analysis

    Jul 1, 2022, 00:00

  • Author's Reply

    Jul 1, 2022, 00:00

  • EE132 Cost-Utility and Budget Impact Analysis of Implementing Anticoagulation Clinics and Point-of-Care Monitoring Devices in Anticoagulated Patients in Argentina

    Jul 1, 2022, 00:00

  • EPH161 A Scoping Review on Estimation of Economic Burden of Chronic Kidney Diseases in India

    Jul 1, 2022, 00:00

  • HTA10 Update of the Health Technology Assessment Progress in Ukraine: Implementation and Impact in 2021

    Jul 1, 2022, 00:00

  • EPH121 A Descriptive Study on Hospital-Related Coronavirus Disease 2019 (HRCOVID-19) Among Chronic Kidney Disease Patients during the Pandemic at a Tertiary Center in the Philippines

    Jul 1, 2022, 00:00

  • EE244 Cost-Effectiveness of Adding Sodium-Glucose Cotransporter 2 Inhibitors to Standard of Care Among Patients with Heart Failure and a Reduced Ejection Fraction

    Jul 1, 2022, 00:00

  • EE218 Burden of Chronic Kidney Disease in Type 2 Diabetes Using the Standard of Care in Colombia

    Jul 1, 2022, 00:00

  • CO126 Effectiveness of Six PD-1/PD-L1 Inhibitors in Treatment of Patients with Advanced Squamous Non-Small Cell Lung Cancer: An Indirect Comparison and Partitioned Survival Model

    Jul 1, 2022, 00:00

  • P54 Patient Preferences for Treatment of BCG-Unresponsive Non-Muscle Invasive Bladder Cancer: A Discrete Choice Experiment

    Jul 1, 2022, 00:00

  • MSR12 Eliciting Unreported Subgroup-Specific Survival in Randomized Controlled Trials (RCTS): A Non-Parametric Linear Optimization Approach

    Jul 1, 2022, 00:00

  • MSR32 Data Sampling Methods for Imbalanced Classification: A Random Forest Study for Predicting Treatment Switching in Multiple Sclerosis

    Jul 1, 2022, 00:00

  • MSR34 A Pragmatic Guide to Assessing Real Option Value for Medical Technologies

    Jul 1, 2022, 00:00

  • EE429 A Systematic Review of Healthcare Resource Use and Costs of the Treatment of Clostridioides Difficile Infections

    Jul 1, 2022, 00:00

  • EPH117 Factors Associated with Receipt of Second Dose of mRNA-1273 Vaccine at Walgreens Pharmacies during the COVID-19 Pandemic

    Jul 1, 2022, 00:00

  • HTA28 A Comparative Review of Pharmacoeconomic (PE) Guidelines in ASIA-Pacific (APAC) with Europe and North America

    Jul 1, 2022, 00:00

  • CO142 Determinants of Pediatric Nurses' Burnout: Integrating Compassion Satisfaction - Compassion Fatigue and Empowerment Models

    Jul 1, 2022, 00:00

  • EPH51 Associations between Psychiatric Disorders and COVID-19 in Japan: Results from the Life Study

    Jul 1, 2022, 00:00

  • HSD35 Real-World Treatment Patterns Among US Adolescents with Alopecia Areata: A Retrospective Claims Analysis

    Jul 1, 2022, 00:00

  • HTA52 Comparing the Change from Base Case to Re-Analyzed ICER Values for CADTH Oncology Evaluations

    Jul 1, 2022, 00:00

  • HSD52 Examining Treatment Patterns of Topical Therapies Among Adolescent and Adult Patients with Atopic Dermatitis in the United States

    Jul 1, 2022, 00:00

  • EE43 Budget Impact Analysis of Favipiravir (AVIGAN®) for the Treatment of Patients with Confirmed Infection with SARS-COV2 in Mexico

    Jul 1, 2022, 00:00

  • EPH95 Frequency of and Testing Patterns for Microsatellite Instability High (MSI-H) and Deficient Mismatch Repair (DMMR) Among Solid Tumors in a US Community Oncology Setting

    Jul 1, 2022, 00:00

  • EE467 Recovid Study. Cost-Effectivness Analysis of Using Nutridrink 200 ML in the Treatment of COVID-19 in the Hospital

    Jul 1, 2022, 00:00

  • P76 Comparative Adherence Trajectories across Oral Disease-Modifying Agents in Multiple Sclerosis

    Jul 1, 2022, 00:00

  • MSR28 Applied Comparison of Indirect Covariate Balance and Residual Confounding: Propensity Score Matching Versus Cardinality Matching

    Jul 1, 2022, 00:00

  • EE222 Indirect Cost Associated with Stroke-Related Disability: The Role of Learning Curves for Mechanical Thrombectomy in Improving Outcomes and Costs in Chile

    Jul 1, 2022, 00:00

  • CO147 Driving Outcomes in Mild Cognitive Impairment/Alzheimer's Disease - a Review of Association between Driving Simulator Measures and Clinical Outcomes Assessments

    Jul 1, 2022, 00:00

  • A Conceptual Framework for Life-Cycle Health Technology Assessment [Editor's Choice]

    Jul 1, 2022, 00:00

  • EE82 Economic Modelling of Gene Therapies Based on the Comparison of Two Independent Models Assessing Voretigene Neparvovec for RPE65 - Mediated Inherited Retinal Dystrophy

    Jul 1, 2022, 00:00

  • EE254 Biosimilars Impact on the Rheumatoid Arthritis Treatment: A Cost-Effectiveness Model from Spanish National Healthcare System Perspective

    Jul 1, 2022, 00:00

  • EE116 Implications of Utilizing Survey Versus Administrative Claims Data to Evaluate the Cost of Diabetes Among Medicare Beneficiaries with Cancer: A Methods Study

    Jul 1, 2022, 00:00

  • EE383 Medical Expenditures and Health Care Utilization: A Comparison Among U.S. Adult Tobacco Consumers (I.E. NEVER TOBACCO USERS, CIGARETTE SMOKERS AND SMOKELESS TOBACCO USERS)

    Jul 1, 2022, 00:00

  • EE281 Evaluation of Health Care Resource Utilization and Costs Among Bio Naïve Crohn’s Disease Patients Initiating Biologics with Two Years of Follow-up

    Jul 1, 2022, 00:00

  • CO114 Real-World Reductions in Acute Medication Use for Patients with Migraine Initiating Fremanezumab: A 12-Month Retrospective US Claims Analysis

    Jul 1, 2022, 00:00

  • EE147 The Cost-Effectiveness of Olaparib Compared to Niraparib in the Treatment of Recurrent Ovarian Cancer Caused By BRCA1 and BRCA2 Gene Mutation from a US Healthcare Payer Perspective.

    Jul 1, 2022, 00:00

  • EE382 Healthcare Utilization, Employment and Sickness Absence Among Patients with Psoriasis and Psoriatic Arthritis in Sweden: Descriptive Analysis from a Nationwide Register-Based Study

    Jul 1, 2022, 00:00

  • EPH169 The Effect of Drug Exposure on Parkinsonism Incidence in Pediatrics

    Jul 1, 2022, 00:00

  • EE220 Comprehensive Nutrition Program Informs Potential Cost-Savings for Latin American Hospitals: A Budget Impact Analysis

    Jul 1, 2022, 00:00

  • HPR12 Assessment of the French National Experimentation for Incentivising Hospital Prescriptions of Adalimumab Biosimilars Delivered in Retail Pharmacies

    Jul 1, 2022, 00:00

  • HPR19 Developing Evidence for Improving Childhood Vaccine Adoption and Uptake in Low- and Middle-Income Countries: A Systematic Review

    Jul 1, 2022, 00:00

  • Qualitative and Quantitative Evidence on the Patient-Caregiver Dyad

    Jul 1, 2022, 00:00

  • EE80 Cost-Effectiveness Analysis of Hemodialysis Vs. Peritoneal Dialysis Among Patients with End-Stage Renal Disease

    Jul 1, 2022, 00:00

  • EE287 Economic Model for Trivalent to Quadrivalent Influenza Vaccination Switch for Type 2 Diabetes Mellitus 40-64 Years Old Patients in Colombia

    Jul 1, 2022, 00:00

  • HTA60 Health Disparities in Health Technology Assessment: An Opportunity for Improvement

    Jul 1, 2022, 00:00

  • EE104 Cost-Utility of a Digital Wellness Intervention for Managing Depression and Anxiety Symptoms: A Payer Perspective

    Jul 1, 2022, 00:00

  • MSR11 A Step-By-Step Guide for Causal Study Design When Estimating Treatment Effects Using Real-World Data

    Jul 1, 2022, 00:00

  • P47 Integrating a Polygenic Risk Score for Coronary Artery Disease As a Risk Enhancing Factor in the Pooled Cohort Equation: A Cost-Effectiveness Analysis Study

    Jul 1, 2022, 00:00

  • EE86 Epilepsy-Related Healthcare Resource Use and Costs in Commercially Insured Patients Before and After Initiating Brivaracetam: A Retrospective Claims Database Analysis

    Jul 1, 2022, 00:00

  • P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study

    Jul 1, 2022, 00:00

  • EPH167 Recursive Partitioning Analysis of COVID-19 Risk and Behavioral Measures in an Urban Setting

    Jul 1, 2022, 00:00

  • MSR8 Revolutionizing Drug Discovery and Preclinical Research Via Artificial Intelligen A Targeted Literature Review

    Jul 1, 2022, 00:00

  • HSD48 Real World Treatment Patterns Among US-Based Metastatic Hormone Sensitive Prostate Cancer (MHSPC) Patients: Results from Syndicated Chart Reviews

    Jul 1, 2022, 00:00

  • Appraising the Costs of Genomic Testing for Histology-Independent Technologies: An Illustrative Example for NTRK Fusions

    Jul 1, 2022, 00:00

  • EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata

    Jul 1, 2022, 00:00

  • EE438 Assessing the Budget Impact of Automated Diabetic Retinopathy Screening: A Budget Impact Analysis in Germany

    Jul 1, 2022, 00:00

  • CO80 Canada National and Provincial Cataract Surgery Wait Times (2017-2021): A Targeted Literature Review

    Jul 1, 2022, 00:00

  • EPH39 Potential Predictors of Length of Hospital Stay Among Corona-Virus Patients in Saudi Arabia: A Single Hospital Retrospective Cohort Study

    Jul 1, 2022, 00:00

  • EE507 Accuracy of Transferred Medical Costs: Evidence from the Middle East and North Africa Region

    Jul 1, 2022, 00:00

  • EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share

    Jul 1, 2022, 00:00

  • P48 Are Health Technology Assessment (HTA) Bodies Responding to the Assessment Challenges Posed By Cell and Gene Therapies?

    Jul 1, 2022, 00:00

  • EE495 Threshold Price in the US to Achieve Cost-Effective Use of Molnupiravir and PF-07321332/Ritonavir for the Prevention of Severe COVID-19 in High-Risk Adults

    Jul 1, 2022, 00:00

  • HSD33 Patient Utilization and Switching Patterns of Patient Assistance Programs (PAPs) for Monoclonal Antibodies Targeting the Calcitonin Gene-Related Peptide (CGRP) Pathway for Migraine Prevention: A Retrospective Cohort Study

    Jul 1, 2022, 00:00

  • MSR30 Modelling Monthly Migraine Day Distribution: A Case Study of Fremanezumab Japanese-Korean Clinical Trials for Migraine Prevention

    Jul 1, 2022, 00:00

  • EPH112 Healthcare Utility and Expenditures in Patients with Tricuspid Regurgitation: A Population-Based Cohort Study

    Jul 1, 2022, 00:00

  • CO150 Examining the Relationship between Prolonged QTc Risk Score and in-Hospital Mortality

    Jul 1, 2022, 00:00

  • EPH21 Real-World Evidence of Adverse Kidney Outcomes for Intravitreal Use of Vascular Endothelial Growth Factor (VEGF) Inhibitors Among Patients with Diabetic Retinopathy

    Jul 1, 2022, 00:00

  • HTA46 Key Issues in Health Economic Analysis in Nice Highly Specialised Technology Appraisals

    Jul 1, 2022, 00:00

  • HPR52 Health Policy Implementations Related to Unhealthy Lifestyle in Who Regions

    Jul 1, 2022, 00:00

  • EE41 Cost-Effectiveness of Anti-BCMA CAR T-Cell Therapy in Triple-Class Refractory Multiple Myeloma

    Jul 1, 2022, 00:00

  • HPR20 The Landscape of U.S. Orphan Product Designations and Approvals

    Jul 1, 2022, 00:00

  • CO112 Adjusting Overall Survival Estimates after Treatment Switching in Pulmonary Arterial Hypertension: Results from the Seraphin Randomized Study

    Jul 1, 2022, 00:00

  • EPH55 Association Between Prior Bisphosphonate Use and COVID-19-Related Outcomes

    Jul 1, 2022, 00:00

  • CO89 Association of Antipsychotic-Related Weight Gain and Treatment Adherence and Switching Using Medical Records Data

    Jul 1, 2022, 00:00

  • CO2 Indirect Treatment Comparison between Daprodustat and Roxadustat in Non-Dialysis Patients with Anemia Associated with Chronic Kidney Disease: An Analysis of Energy/Fatigue as Measured by the SF-36 Vitality Score

    Jul 1, 2022, 00:00

  • EE98 A Budget Impact Analysis of Empagliflozin for Treatment of Patients with Type 2 Diabetes Mellitus at Increased Cardiovascular Risk in Tertiary Hospital, Riyadh, Saudi Arabia

    Jul 1, 2022, 00:00

  • EE399 AD Valorem: Alzheimer’s Disease, Atopic Dermatitis, and Challenges for Value Assessment in Chronic Conditions

    Jul 1, 2022, 00:00

  • CO49 Clinical Efficacy and Safety of Therapeutic Interventions Used in Friedreich Ataxia: A Systematic Review

    Jul 1, 2022, 00:00

  • EE338 Cost-Effectiveness Analysis of Arthroscopic Injection of a Bioadhesive Hydrogel Implant in Conjunction with Microfracture for the Treatment of Focal Chondral Defects of the Knee: An Australian Perspective

    Jul 1, 2022, 00:00

  • CO4 Development of an Administrative Claims and Electronic Medical Record-Based Algorithm to Classify Systemic Disease Severity Among Patients with Sjogren's Syndrome in an Integrated Delivery Network in the United States

    Jul 1, 2022, 00:00

  • CO7 Patient Reported Outcome Measure for Giant Cell Arteritis: Cross-Sectional Validation Study

    Jul 1, 2022, 00:00

  • EPH106 Comparison of the Post-Marketing Safety Profile between Influenza and COVID-19 Vaccines: An Analysis of the Vaccine Adverse Event Reporting System (VAERS)

    Jul 1, 2022, 00:00

  • EPH34 The Burden of Ventilator-Associated Pneumonia Based on Time on a Mechanical Ventilator: A Retrospective Analysis of the MIMIC IV Database

    Jul 1, 2022, 00:00

  • HSD106 Factors Associated with Lost-to-Follow-up Status in Community Pharmacy Among Chinese Cancer Patients Using PD-1/PD-L1

    Jul 1, 2022, 00:00

  • How Do Patients Value the Benefit of Minimally Invasive Surgery in Cancer Treatment?

    Jul 1, 2022, 00:00

  • EE55 A USRDS Retrospective Cohort Study: Epidemiology, Treatment Modalities, and Burden of End-Stage Kidney Disease Attributed to Immunoglobulin A Nephropathy

    Jul 1, 2022, 00:00

  • EE496 Twelve-Month Inpatient Mortality and Economic Burden of Clostridioides Difficile Infections in the US: 2016-2019

    Jul 1, 2022, 00:00

  • CO146 Readmission and Mortality Following Discharge from Inpatient Treatment for COVID-19 By Mechanical Ventilation Status in Early and Late Phases of the Pandemic

    Jul 1, 2022, 00:00

  • P63 Cost Effectiveness of Cabozantinib Plus Nivolumab As First-Line Treatment for Renal Cell Carcinoma

    Jul 1, 2022, 00:00

  • CO37 Real-World 30-Day Readmission Patterns Among Commercially Insured Patients with Metastatic Pancreatic Ductal Adenocarcinoma (MPDAC)

    Jul 1, 2022, 00:00

  • Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group

    Jul 1, 2022, 00:00

  • EE314 Relative Frequency, Healthcare Resource Utilization, and Costs of Diagnosed Drug-Induced Headache and Potential Acute Medication Overuse in Patients with Migraine

    Jul 1, 2022, 00:00

  • P36 The Impact of COVID-19 Diagnosis on Healthcare Costs

    Jul 1, 2022, 00:00

  • HPR68 Timing of Initiation of Clinical Interventions in Patients with Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence

    Jul 1, 2022, 00:00

  • EE444 Annual Health Insurance Treatment Cost of Ovarian Endometriosis Based on Real-World Health Insurance Claims Data

    Jul 1, 2022, 00:00

  • HSD101 Lack of concordance between real-world treatment patterns and clinical guideline recommendations for metastatic hormone-sensitive prostate cancer (mhspc) patients

    Jul 1, 2022, 00:00

  • EE488 Solve Study: Costs Related to Logistics and Storage of Fully Liquid Acellular Hexavalent Vaccine in Brazil

    Jul 1, 2022, 00:00

  • EPH100 Assessment of Psychological Responses of the Indian Population Due to COVID-19 Pandemic: A Web-Based Survey

    Jul 1, 2022, 00:00

  • HPR75 Representation and Equity in Utility Assessments Used for Cost-Effectiveness Analyses

    Jul 1, 2022, 00:00

  • EE453 The Singapore Diabetes Prevention Program Cost-Effectiveness Analysis Revisited: Proper Methods Overturn Previous Conclusions

    Jul 1, 2022, 00:00

  • EE504 Cost-Utility Analysis Comparing Direct Oral Anticoagulant (DOAC) and Low-Molecular-Weight Heparin (LMWH) Therapies for Cancer-Associated Thrombosis (CAT) Treatment in the United States

    Jul 1, 2022, 00:00

  • EPH92 Investigating Undergraduate Students’ Perception on COVID-19 Pandemic and Social Distance and Its Influencing Factors By Association Analysis and Sentimental Analysis

    Jul 1, 2022, 00:00

  • EE78 Impact of Empagliflozin in Reducing Hospitalization Rates in Type 2 Diabetes Mellitus Patients with Chronic Heart Failure

    Jul 1, 2022, 00:00

  • EE65 Aspects Affecting Quality of Life in Patients with Rare Disease and Their Carers: Are Current Utility Instrument Capturing Enough?

    Jul 1, 2022, 00:00

  • CO15 Flexibility in Water and on Land over 50 Years

    Jul 1, 2022, 00:00

  • HSD43 Impactability Score: A New Tool in the Management of High-Risk Members

    Jul 1, 2022, 00:00

  • CO60 Real-World Effectiveness of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Population-Based Study in South Korea

    Jul 1, 2022, 00:00

  • MSR6 Modeling Survival of People with Cystic Fibrosis (PWCF) Aged ≥6 Years Heterozygous for the F508DEL Mutation with a Minimal Function Mutation (F/MF) in Brazil Treated with Elexacaftor/Tezacaftor/Ivacaftor and Ivacaftor (ELX/TEZ/IVA)

    Jul 1, 2022, 00:00

  • P14 Identification of COVID-19 Vaccine Hesitancy Predictors

    Jul 1, 2022, 00:00

  • EE129 A Cost-Effectiveness Analysis for Terlipressin in Treating Bleeding Oesophageal Varices Patients in the Philippines

    Jul 1, 2022, 00:00

  • EE291 Psoriasis-Related Work Productivity Improvement from a Phase 4 Real-World Study Interim Analysis of Tildrakizumab in Patients with Moderate to Severe Psoriasis

    Jul 1, 2022, 00:00

  • HPR31 Impact of Telehealth Use during the COVID-19 Pandemic on Glycemic Control and Other Biomarkers Among Type 2 Diabetes Patients

    Jul 1, 2022, 00:00
  • «
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39 (current)
  • 40
  • »